Navigation Links
Precyse Solutions Honored as 'Technology Company of the Year'
Date:11/20/2008

Benchmark measures key performance indicators of HIM departments against industry standards to determine areas of strength and needed improvement. Precyse's services support best practices in multiple areas including: remote and on-site coding, transcription, audit and education, cancer registry, consulting and interim/long-term management services. For more information, please visit http://www.precysesolutions.com.

About the Eastern Technology Council

The Eastern Technology Council serves leaders of more than 700 technology and life sciences companies by providing valuable contacts and capital, information and education, through a wide variety of events, publications, and innovative services.

The Council provides a business culture that embraces start-ups and established companies by promoting, supporting, growing, funding, and rewarding entrepreneurial activities in the region in an effort to promote growth and successful businesses. Online at http://www.easterntechnologycouncil.org.

    Media Contact:
    Anne Marie Heil
    AMHeil Marketing Strategy + Communications
    amheil@amheil.com
    610-933-8065

'/>"/>
SOURCE Precyse Solutions
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Precyse Solutions Appoints Karen Heisler as New Corporate Vice President, Human Resources
2. Precyse Solutions Launches Clinical Documentation Improvement Program to Assist Hospitals in Accelerating Revenues
3. Precyse Solutions Promotes Ken Lacy to Senior Vice President & CIO to Drive Advancement of PrecyseNet(TM), Precyses Advanced Technology Solution
4. Precyse Executive Authors New Book, The Legal Health Record
5. Enhanced PrecyseCode 2X(TM) Further Accelerates Remote Coding and Improves Cash Flow for Hospitals
6. HOE Ministries Gives New Hope to Orphans in Ethiopia : Hope For Orphans of Ethiopia Organization to Build Greater Awareness and Solutions to the Soaring Poverty Catastrophe Afflicting Orphaned and Innocent Children in Prison
7. Collexis Healthcare to Expand Capabilities for Asklepios Group Utilizing Microsoft Solutions
8. drugstore.com Announces Strategic Alliance With Medco Health Solutions
9. WebMD and Marketing Technology Solutions Terminate Merger Agreement
10. Insurers Employ Multiple Solutions to Avoid Radiology Expense Spike
11. USA-ONE Interactive Announces Document Management Solutions That Meet the Needs of Individual Industries
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Heska Announces Extension of Credit Agreement With Wells Fargo 2Heska Announces Extension of Credit Agreement With Wells Fargo 3Anesiva Completes Sale of its Zingo(TM) Assets to Powder Pharmaceuticals and Lee's Pharmaceuticals 2St. Luke's Hospital Acquires Pioneering Technology From BrainLAB 2St. Luke's Hospital Acquires Pioneering Technology From BrainLAB 3Sanofi aventis and Merrimack Pharmaceuticals Enter Into a Worldwide Collaboration and Licensing Agreement on MM 121 an Anti ErbB3 Monoclonal Antibody 5122 1Sanofi aventis and Merrimack Pharmaceuticals Enter Into a Worldwide Collaboration and Licensing Agreement on MM 121 an Anti ErbB3 Monoclonal Antibody 5122 2Sanofi aventis and Merrimack Pharmaceuticals Enter Into a Worldwide Collaboration and Licensing Agreement on MM 121 an Anti ErbB3 Monoclonal Antibody 5122 3Sanofi aventis and Merrimack Pharmaceuticals Enter Into a Worldwide Collaboration and Licensing Agreement on MM 121 an Anti ErbB3 Monoclonal Antibody 5122 4Sanofi aventis and Merrimack Pharmaceuticals Enter Into a Worldwide Collaboration and Licensing Agreement on MM 121 an Anti ErbB3 Monoclonal Antibody 5122 5Sanofi aventis and Merrimack Pharmaceuticals Enter Into a Worldwide Collaboration and Licensing Agreement on MM 121 an Anti ErbB3 Monoclonal Antibody 5122 6Sanofi aventis and Merrimack Pharmaceuticals Enter Into a Worldwide Collaboration and Licensing Agreement on MM 121 an Anti ErbB3 Monoclonal Antibody 5122 7Sanofi aventis and Merrimack Pharmaceuticals Enter Into a Worldwide Collaboration and Licensing Agreement on MM 121 an Anti ErbB3 Monoclonal Antibody 5122 8Sanofi aventis and Merrimack Pharmaceuticals Enter Into a Worldwide Collaboration and Licensing Agreement on MM 121 an Anti ErbB3 Monoclonal Antibody 5122 9Golden Meditech Announces HK 24217 Million Private Equity Financing for Hospital Subsidiary 14309 1Golden Meditech Announces HK 24217 Million Private Equity Financing for Hospital Subsidiary 14309 2Method to Identify Female Athletes at a High Risk for Knee Injury Discovered 58628 1Method to Identify Female Athletes at a High Risk for Knee Injury Discovered 58628 2